161
Views
5
CrossRef citations to date
0
Altmetric
CLINICAL TRANSLATIONAL RESEARCH

Phase II Trial Assessing Granulocyte-macrophage—Colony Stimulating Factor, Ketoconazole Plus Mitoxantrone in Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Treatments

, &
Pages 177-182 | Received 08 Mar 2012, Accepted 06 Jan 2013, Published online: 12 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek & Jerzy Gubernator. (2014) Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies. International Journal of Nanomedicine 9, pages 653-668.
Read now

Articles from other publishers (4)

Marco Sisignano, Dieter Steinhilber, Michael J. Parnham & Gerd Geisslinger. (2020) Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications. Drug Discovery Today 25:9, pages 1744-1753.
Crossref
Wenxin Xu & Glenn J. Bubley. (2019) Repurposed Drugs for Prostate Cancer. The Cancer Journal 25:2, pages 121-126.
Crossref
Vaibhav Patel, Bobby Liaw & William Oh. (2018) The role of ketoconazole in current prostate cancer care. Nature Reviews Urology 15:10, pages 643-651.
Crossref
Yuxuan Xin, Qi Qi, Zhenmin Mao & Xiaoping Zhan. (2017) PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations. International Journal of Pharmaceutics 528:1-2, pages 47-54.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.